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ABSTRACT
Background: Regional anesthesia has been at the forefront of opioid-sparing anesthesia. It has
been proven time and again to be an effective method of safely and effectively controlling pain
throughout the surgical process. Cardiac surgery presents its challenges to performing regional
techniques due to the excessive amount of anticoagulation required to perform this type of
surgery. The thoracic erector spinae plane block is a promising technique that has been shown to
provide adequate pain control and is a safe alternative in patients who are anticoagulated
compared to other regional techniques.
Objectives: The purpose of this study is to increase anesthesia provider knowledge on the value
of the use of the ESP block for cardiac surgery. A literature review including primary research
studies addresses the PICO question: “In anticoagulated patients undergoing general anesthesia
for cardiac surgery, are erector spinae plane blocks when compared to thoracic epidurals,
thoracic paravertebral blocks, and traditional methods safer to use while providing adequate
perioperative analgesia?” The literature review is utilized to deliver the educational structure to
increase provider knowledge. The objective is to increase provider awareness to improve patient
outcomes and satisfaction related to cardiac surgery.
Methodology: The primary methodology of the proposed project is to administer an online
educational intervention to providers which focuses on the benefits of the ESP block for cardiac
surgery. Pre- and post-assessment surveys will be used to measure the improvement of provider
knowledge before and after the intervention. The likelihood of use and recommendation of the
ESP block for cardiac surgery will also be assessed.
Results: There was an overall improvement in provider knowledge following the educational
intervention. The likelihood of utilizing and recommending the ESP block improved overall as
well.
Conclusions: The evidence shows that the thoracic ESP block is a promising safe and effective
tool for patients undergoing cardiac surgery via sternotomy or thoracotomy compared to the
thoracic epidural, thoracic paravertebral block, and traditional methods. More research must be
conducted via randomized controlled trials to ensure its safety and effectiveness.
Keywords: Erector spinae plane block, cardiac surgery, adult, regional anesthesia, thoracic
epidural, thoracic paravertebral block, traditional methods
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INTRODUCTION
Description of Problem
High thoracic epidurals (HTEs) and thoracic paravertebral blocks (TPVBs) are not
widely used for cardiac surgery due to the severity of the adverse effects of performing the
blocks on anticoagulated patients. A significant complication from HTEs, especially in an
anticoagulated patient, is the risk of epidural hematoma, which is known to cause severe
neurologic deficits.1 It also is known to cause pruritis, nausea, vomiting, urinary retention, and in
some cases, respiratory depression from epidural opioids.1 TPVBs, although a better option than
HTEs with a lower incidence of complications, still carry the inherent risk of a spinal hematoma
and epidural abscess.2 In addition to these, there is also the risk of accidental vascular puncture,
hypotension, epidural or intrathecal spread, puncture of the pleura, and pneumothorax.3 The
likelihood of pneumothorax and vascular puncture was higher using a bilateral block as opposed
to a unilateral block, which would be required in complete blockage for sternotomy incision.3
The inherent risks of performing HTEs and TPVBs are unfortunate, most notably in
anticoagulated cardiac surgical patients. Unless a regional technique is found that minimizes the
significant risks while providing adequate blockade, high opioid use during cardiac surgery will
continue to be utilized.
One of the most common surgeries in America is coronary artery bypass grafting
(CABG), costing an average of $44,820.4 Fast-track, multimodal approaches to cardiac surgery
have been proven to be safer for patients and more cost-effective than traditional methods of
high opiate use.5 A key aspect of this approach is regional anesthesia. Thoracic erector spinae
plane (ESP) blocks have been shown to have an adequate analgesic effect comparable to HTEs
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on cardiac surgical patients.6 Considering that HTEs and TPVBs have similar pain control, it
could be hypothesized that ESP blocks would have similar results in analgesia when compared to
TPVBs. ESP blocks may potentially be the future of managing pain in cardiac surgery.
Background and Significance
Regional anesthesia has been at the forefront of opioid-sparing/free analgesia in recent
years when it was discovered how dangerous opioids could be to those who liberally use them.
There are many different regional techniques anesthesia providers utilize tailored to specific
surgeries patients undergo. Traditionally, cardiac surgery has brought about its challenges
regarding regional anesthesia due to the required presence of systemic heparinization intra- and
postoperatively.7 This anticoagulated state brings about many risks related to the placement of
HTEs and TPVBs, causing providers to administer them hesitantly. Considering HTEs and
TPVBs are the gold standards in managing thoracic surgical pain, this has forced anesthesia
providers to look towards other regional techniques that are as effective as these and safe to
perform in an anticoagulated state.8
ESP block is one of the newest regional techniques discovered in the last few years to
treat chronic thoracic neuropathic pain and postoperative pain in thoracic surgery.9 The ESP
block exerts its effects by diffusing local anesthetic anteriorly to the paravertebral and epidural
spaces and laterally to the intercostal space at multiple levels blocking the nerves that supply the
anterolateral wall of the thorax.9 This block is not only relatively superficial; it's also distant from
significant vessels and nerves, pleura, and the spinal cord.10 These attributes make the ESP block
a strong candidate for anticoagulated patients having cardiac surgery, considering the risk of
serious complications is minimized. Multiple case studies in which the ESP block was performed
for cardiac surgery showed adequate pain control with no adverse effects from anticoagulation.
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Although more randomized controlled trials must be conducted to ensure the safety and efficacy
of the ESP block, this regional technique shows promise for safely and effectively providing
adequate perioperative analgesia for patients undergoing cardiac surgery.
Purpose of the Study
This study aims to increase anesthesia provider knowledge on the value of the use of the
ESP block for cardiac surgery. A literature review including primary research studies addresses
the PICO question: "In anticoagulated patients undergoing general anesthesia for cardiac
surgery, are erector spinae plane blocks when compared to thoracic epidurals, thoracic
paravertebral blocks, and traditional methods safer to use while providing adequate perioperative
analgesia?" The literature review is utilized to deliver the educational structure to increase
provider knowledge. The objective is to increase provider awareness to improve patient
outcomes and satisfaction related to cardiac surgery.
LITERATURE REVIEW
Purpose of the Literature Review
Safely providing adequate analgesia for patients undergoing cardiac surgery using
regional techniques presents significant challenges related to the significant amount of
anticoagulation required during and after cardiopulmonary bypass. Finding a regional technique
that provides adequate perioperative analgesia without serious adverse effects in anticoagulated
patients is crucial. Without this technique, cardiac surgery will continue to rely heavily on
opioids, which have been proven to cause more harm than good.
The first objective of this review is to determine whether ESP blocks are safe to use in
anticoagulated patients. The second objective is to research whether ESP blocks have
comparable or better pain control than TPVB, thoracic epidurals, and traditional methods. Once
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ESP blocks have been proven to cause adequate perioperative analgesia, a plan will be put into
place to include ESP blocks in future enhanced recovery after surgery (ERAS) protocols. The
ESP block will be a crucial component of the ERAS protocols to ensure safe, cost-effective care
for cardiac surgery patients.
Methodology
Databases and Search Strategy
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)
statement contains a 27 item checklist and a four-phase flow diagram that aims to aid authors in
improving the reporting of systematic reviews and meta-analyses.11 It was utilized during this
study to guide the search of this systematic review. The search used PubMed, Cumulative Index
of Nursing and Allied Health Literature (CINAHL), MEDLINE (Proquest), and Excerpta Medica
Database (EMBASE). To effectively search through these databases, a PICO format question
was utilized to develop keywords and concepts. The keywords used include erector spinae plane
block, cardiac surgery, adult, regional anesthesia, thoracic epidural, and thoracic paravertebral
block. The PubMed database produced 70 articles, CINAHL yielded 26 articles, MEDLINE
resulted In 21 articles, and EMBASE gave 81 articles. A total of 198 articles were found using
these databases. Based on the PICO format, a clinical question was created to guide this
research: (P) In anticoagulated patients undergoing general anesthesia for cardiac surgery, (I) are
erector spinae plane blocks (C) when compared to thoracic epidurals, thoracic paravertebral
blocks, and traditional methods (O) safer to use while providing adequate perioperative
analgesia?
Study Selection and Screening Method
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Many studies were found through the different databases that needed to be screened to
ensure they were related to the PICO question. Endnote was a software tool that was used to
remove duplicate studies and organize the studies found. Of the 198 articles found, 45 duplicates
were removed, and 153 articles were screened. Refer to table 2 to understand the
inclusion/exclusion criteria used to filter the remaining articles. One hundred thirty-three articles
were excluded based on the exclusion criteria. Of the 20 articles left, seven will be used in this
review based on the criteria and the PICO question.
Table 1. Inclusion and Exclusion Criteria
Inclusion
Population:
• Male and Female
• Adults
Type of procedure:
• ESP block
• Comparison of ESP block versus TPBP or HTE
• Cardiac surgery via midline sternotomy or
thoracotomy
• Surgeries requiring thoracotomy
Primary outcomes:
• Decreased opioid use
• ESP block effectively controls pain in the
perioperative setting
• Safe to use in anticoagulated patients
Type of study:
• English language
• Randomized controlled trials
• Publication date 2015-Present
• Case Studies
• Systematic reviews
• Meta-analysis
• Questionnaire
• Dissertations/theses

Exclusion
Population:
• Children (<18 years old)
Type of procedure:
• Anything other than cardiac
surgery or surgery requiring
thoracotomy
Outcomes:
• Anything other than
hypotension, bradycardia,
vasopressor use (e.g., pruritus)
Type of study:
• Non-English
• Publication date pre-2015
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Figure 1. PRISMA Flow Diagram

Records identified through
database searching
(n = 198)

Additional records
identified through other
sources
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Screening

Records after duplicates removed
(n =45)
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(n = 153)
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Eligibility

Full-text articles assessed
for eligibility
(n = 20)

Studies included in
qualitative
synthesis
(n = 7)

Records excluded
(n = 133)

Full-text articles
excluded, with
reasons
(n = 13)
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Collection, Analysis, and Data Items
The John Hopkins Evidence-Based Practice tool helps evaluate the quality and strength
of evidence used for research.12 This tool uses level I-V to determine the strength of evidence
and uses grades A-C to assess the quality of evidence.12 Level I consist of experimental studies,
randomized control trials (RCTs), and these can be with or without meta-analysis.12 Level II
consists of quasi-experimental studies and level III consist of non-experimental studies.12 Level
IV is considered an opinion of respected authorities or nationally recognized expert committees
and can include clinical practice guidelines (CPG), consensus panels, or case studies.12 Level V
is based on experimental and non-research evidence.12 Grade A is evidence of high quality with
clear aims and objectives showing consistent results.12 Grade B is considered evidence of good
quality that has consistent results in a single setting.12 Grade C is evidence of low quality or with
major flaws.12
The investigator used the John Hopkins’ evidence appraisal tool to effectively and
efficiently evaluate the studies. A table was made to aid in summarizing and classifying the
features of each study. In this table, the level of evidence was provided. Along with the level of
evidence, the table included: (1) Article citation and title, (2) the design/method of the study, (3)
the sample and setting, (3) major variables studied, (4) measurement and data analysis, (5)
findings of the study, and (6) conclusions.
Results
Study Selection
The four databases that were utilized yielded a total of 198 articles initially. Of the 198,
45 duplicates were removed, and a total of 153 articles were left for further review. After further
inspection, 133 articles were excluded, and a total of 20 full-text articles were evaluated for their
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suitability. A full-text evaluation was completed based on the inclusion and exclusion criteria,
and 13 of the remaining were excluded for multiple reasons, including: pediatric population, type
of procedure, any study published before 2015, and language other than English. Ultimately, the
study selection resulted in 4 RCTs, one consecutive patient-matched controlled before-and-after
study, and two case series that were used in this systematic qualitative review. This review
answered the PICO question: "In anticoagulated patients undergoing general anesthesia for
cardiac surgery, are erector spinae plane blocks when compared to thoracic epidurals, thoracic
paravertebral blocks, or traditional methods, safer to use while providing adequate perioperative
analgesia?” The four RCTs are level I evidence, while the study conducted by Macaire et al.
(2019) is level II, and the two case series are level IV according to Johns Hopkins' appraisal
scale.13 Table 2 provides a summary of all studies included in the systematic review.
Table 2. Studies Included in the Appraisal
Author (Year)
& Level of
Evidence

Study, Participants,
Interventions, & Setting

Findings

Krishna et al.
(2019)
Level I

106 adult patients undergoing elective
cardiac surgery who were randomly
divided into group 1, ESP block, and
group 2, conventional pain
medications. 53 patients received
USG single-shot bilateral ESP block
with 3ml/kg of 0.375% ropivacaine
and 53 received paracetamol 1gm
every 6 hours and tramadol 50mg
every 8 hours intravenously
postoperative

The median pain score at rest after
extubation in group 1 was 0 of 10 until
hour 6, 3 of 10 at hour 8, and 4 of 10 at
hours 10 and 12 post-extubation. These
were significantly less in comparison with
group 2 (p = 0.0001). Patients in group 1
had a significantly higher mean duration of
analgesia (8.98 ± 0.14 hours), during
which NRS was < 4 of 10, compared with
group 2

Singh et al. (2018)

Fifty adult patients undergoing
cardiac surgery were randomly
assigned to Group A, TEA, and Group
B, ESP block. 25 received a TEA
bolus dose of 0.25% plain
bupivacaine followed by a continuous
infusion of 0.125% plain bupivacaine
at the rate of 0.1ml/kg/h until 48 hours
post-extubation. 25 received a USG
continuous bilateral ESP block bolus
dose of 0.25% plain bupivacaine 15
ml injected in each of the catheters

Comparable VAS scores were revealed at
0 h, 3 h, 6 h, and 12 h at rest and during
cough in both groups. Group A had a
statistically significant VAS score than
Group B at 24 h, 36 h, and 48 h but the
mean VAS in either of the groups was ≤4
both at rest and during cough. Incentive
spirometry, ventilator, and ICU duration
were comparable between the groups.

Level I
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followed by continuous infusion of
0.125% plain bupivacaine at a rate of
0.1 ml/kg/h until 48h post-extubation

Fang et al. (2019)

Level I

Sobhy et al.
(2020)
Level I

Macaire et al.
(2019)

Level II

Adhikary et al.
(2019)
Level IV

94 pts scheduled for thoracotomy lung
surgeries were randomly assigned to
ESPB group and TPVB group. 47
received single-shot ESPB 20ml of
0.25% bupivacaine, then sufentanil
PCA post-op. 47 received single-shot
TPVB 20ml of 0.25% bupivacaine,
then sufentanil PCA post-o

60 pts undergoing surgery
requiring thoracotomy were
randomly assigned to ESP group
and C group, conventional opioids.
30 received single-shot US-guided
ESP block with 20 ml 0.25%
bupivacaine. 30 control group
received traditional opioids
67 patients were evaluated who
underwent cardiac surgery. Twenty
consecutive open cardiac surgery
patients without ESPB block
receiving IV morphine, IV nefopam,
and paracetamol. 47 consecutive
patients receiving continuous bilateral
ESPB 0.25ml/kg/side of ropivacaine
0.5%, then 8 hours after loading dose,
boluses of 0.2% ropivacaine every 6
hours
A case series detailing five patients
who underwent therapeutic
anticoagulation after LVAD surgery
via thoracotomy approach. Four pts
received continuous ESP block with
20ml of 0.5% ropivacaine followed by
constant infusion of 0.2% ropivacaine
at 6 to 10 mL/h
postoperatively for rescue analgesia.
The fifth pt received the same dosage
of continuous ESPB preoperatively.

There were no significant differences in
pain scores at rest and cough between the
ESPB and TPVB groups in each of the
first two days after surgery. No difference
between the two groups was identified
regarding postoperative sufentanil usage.
There was no statistical difference in
postoperative nausea and vomiting. There
was significantly less hypotension,
bradycardia, hematoma and a higher
success rate of one puncture in the ESPB
group.
Results showed a significant decrease in
total morphine consumption in the first
24 h postoperatively in the ESP group.
Also, when comparing VAS score during
rest and coughing, results showed a
significant decrease in VASR and VASC
at 6, 12, 18, and 24 h postoperatively in the
ESP group.
Morphine consumption in the first 48
hours was significantly decreased in the
ESPB group, as was
intraoperative sufentanil. Times to chest
tube removal, first mobilization, pain
(Visual Analogue Scale) values 2 hours
after chest tube removal, pain values at rest
1 month after surgery, and postoperative
adverse events were significantly
decreased in the ESPB group. There was
no difference between extubation time and
pain during the first mobilization.
Case 1- A 46 kg, a 62-year-old woman
underwent implantation of a HeartWare
(Framingham, MA) LVAD for ischemic
cardiomyopathy. Shortly after block
completion, the patient described
subjective numbness of the left hemithorax
between the T3 to T9 dermatomes. Her
NRS pain score on deep
breathing decreased from 9/10 to 2/10, and
her MIVs increased to 450 mL,
accompanied by a decrease in her resting
respiratory rate from 25 to 11 breaths per
minute.
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Case 2- An 86 kg, 65-year-old man
underwent explantation of a Heartmate II
LVAD after myocardial recovery from the
previous cardiomyopathy. Pt reported NRS
pain scores of 10/10, MIVs less than
500ml. Within 2 hours of ESP block, his
resting pain score had dropped to 0, his
respiratory rate had decreased to 16 from
26 per minute, and his MIVs improved to
1,200 mL. The ESP infusion was
continued for 72 hours, during which time
his pain remained well controlled with
NRS resting pain scores of 0 to 3/10, rising
to 4/10 on coughing.
Case 3- A 94 kg, 59-year-old man
presented for a HeartMate II to HeartMate
III LVAD exchange due to
pump thrombosis.
Pt received continuous bilateral ESP block
after 10/10 NRS pain and MIVs of 200ml.
After the block, there was rapid
improvement in NRS pain scores to 3/10
and in MIVs to 1,000 mL.
Case 4- A 33-year-old man presented for a
HeartMate II to HeartMate III LVAD
exchange due to pump thrombosis. Pt had
NRS 8-10/10 pain and unmeasurable
readings of MIV. After ESP block, pain
improved to 6/10, narcotic requirements
decreased, and MIVS improved to
2,000mL; over the next few days, pain
scores improved to 2-3/10 max of 5/10.
Case 5- An 85 kg, 60-year-old man was
scheduled for elective HeartWare LVAD
implantation. NRS resting pain score of 2
to 3/10 and 5 to 6/10 with deep
inspiration. Pt also received Oral Tylenol
and IV hydromorphone 4mg POD 1 and 2

Munoz-Leyva et
al. (2019)

A case series of five pts undergoing
cardiac surgery via median
sternotomy that were given
continuous bilateral ESPB
preoperatively using 20 ml of 0.25%
bupivacaine with 2.5mcg/ml of
epinephrine through each catheter.
The postoperative regimen comprised
of 0.125% bupivacaine at 8ml/h
through each catheter as well as 1g of
acetaminophen every 6 hours. IV
hydromorphone given for

There were no adverse events related to
catheter insertion or removal in the cases
described here nor in the subsequent cases
that the authors have performed to date.
Case 1- A 71-year-old woman with
severe aortic stenosis underwent
bioprosthetic aortic valve
replacement surgery. There were no
episodes of breakthrough pain during the
period of ESP catheter infusion.
Subcutaneous enoxaparin (40 mg every 12
hours) also was started during this time as
part of the management of
postoperative atrial fibrillation. Static and
dynamic pain remained well-controlled on
oral acetaminophen (1 g every 6 hours)
with NRS scores of 3 to 4/10 and 1/10,
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breakthrough pain control if bolus
injection of 15ml of 0.125% of
bupivacaine was not effective.

respectively. No opioids were required
during her hospital stay.
Case 2- A 49-year-old man with
severe aortic insufficiency and aortic
root dilation underwent a Bentall
procedure with mechanical valve
prosthesis. The patient reported
breakthrough pain with movement at
postoperative hour 4 and 32 (NRS 5/10
and 6/10, respectively). In both instances,
this was managed by administering a bolus
of 15 mL of 0.125% bupivacaine into
each catheter, which restored adequate
analgesia (static and dynamic NRS pain
scores <4/10). No opioids were required
during the period of ESP
infusion. Anticoagulation with enoxaparin,
1 mg/kg every 12 hours, was started 48
hours following surgery.
Case 3- A 68-year-old man with critical
disease of the proximal anterior
descending and circumflex arteries
underwent a 2-vessel coronary artery
bypass graft surgery with internal
mammary and saphenous vein grafts. The
patient reported dynamic and static NRS
pain scores of 3/10 and 1/10, respectively,
and was started on oral acetaminophen (1 g
every 6 hours) in addition to the ESP
infusion. There were no episodes of
breakthrough pain during his hospital stay,
even after removing the ESP catheters.
Case 4- A 72-year-old man with a severe
aortic insufficiency and aneurysmal aortic
dilatation underwent bioprosthetic aortic
valve replacement and repair of the
supracoronary aortic root with
a Dacron graft. During the first 24 hours of
his postoperative care, the patient received
an infusion of 0.5% lidocaine at 15 mL/h
through each ESP catheter due to a
temporary national shortage of
bupivacaine; thereafter, he received
0.125% bupivacaine. Dynamic and static
NRS pain scores were maintained at 2/10
and 0/10, respectively. There were no
episodes of breakthrough pain or any
requirement for opioids during his hospital
stay.
Case 5- A 64-year-old woman with nonST elevation myocardial infarction and
critical disease of the proximal anterior
descending and circumflex arteries
underwent a 2-vessel coronary artery
bypass graft surgery with internal
mammary and saphenous vein grafts. On
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arrival, the patient reported dynamic and
static NRS pain scores of 8/10 and 4/10,
respectively. A bolus of 15 mL of 0.125%
bupivacaine was administered through
each ESP catheter, which reduced pain
scores by 50% after 15 minutes. Another
episode of breakthrough pain occurred at
postoperative hour 12 (dynamic and static
NRS pain scores of 6/10 and 3/10,
respectively). This again was treated
successfully by bolus administration of
0.125% bupivacaine per protocol, reducing
dynamic and static pain scores to 3/10 and
2/10 within 15 minutes. No further
episodes of breakthrough pain were
reported, even after the removal of the ESP
catheters.

Study Characteristics
The 7 selected studies, when combined, had a total of 387 patients who received an ESP
block for cardiac surgery via thoracotomy or sternotomy. One of the studies evaluated the
effectiveness of the ESP block for surgery requiring thoracotomy. Each study used has
similarities, but it also has some differences as well. For example, one study used bilateral single
shot ESP block, two studies used continuous bilateral ESP block, two used continuous unilateral
ESP block, and two utilized single shot unilateral ESP block. The unilateral ESP block was the
technique applied for the cardiac surgeries requiring thoracotomy and the bilateral approach was
the technique that applied cardiac surgeries via sternotomy.
Definitions and Findings of Outcomes
The studies that were conducted each showed in their way that ESP block, regardless of
technique, was effective in controlling pain for cardiac surgery via a sternotomy or thoracotomy
approach. The approach, whether sternotomy or thoracotomy, guides whether to use a unilateral
or bilateral injection technique. The studies in which a continuous catheter was placed instead of
single-shot proves to be a better approach to controlling pain in the first 48 hours of the surgery.
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Despite being anticoagulated, patients were not found to have bleeding from continuous
catheters. Other adverse effects, when compared to thoracic epidurals and thoracic paravertebral
blocks, were also minimal.
Risk of Bias
Any study conducted has the potential for bias, whether intentional or unintentional.
There are several sources of bias in studies, and the Cochrane Handbook Collaboration's Risk of
Bias tool was utilized to evaluate whether there was bias in any of the seven studies used in this
systematic review.35 4 of the 7 studies had an overall low risk of bias since the samples were
randomly selected. Performance bias must be considered. The RCTs used in this review were
single-blinded, which may leave them open to bias, but it is a low risk. Attrition bias is another
aspect of this tool. There was a low risk of bias in the studies for attrition.
Discussion
Based on the literature review, there was evidence discovered to suggest that the ESP
block is both safe and effective in controlling perioperative pain in cardiac surgery.6,7,10,13-19
When compared to other regional techniques like the HTE and TPVB, the ESP block was found
to have similar pain control with fewer adverse effects.1,2,6,7,13-15 In multiple cases studies, it was
found that the ESP block was safely deployed in heavily anticoagulated patients after left
ventricular assist device implantation.18 Some limitations of the literature review include the
need for further RCTs to increase the study's strength of the ESP block for cardiac surgery. This
additional research would solidify the ESP block as the foundation for fast-track multimodal
opioid-sparing cardiac surgery.
METHODOLOGY
Setting and Participants
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An educational intervention will be conducted to accomplish the goals of this quality
improvement project. This intervention will educate anesthesia providers on the safety and
efficacy of the ESP block for cardiac surgery. The primary setting of this project will take place
online with participants from Mount Sinai Medical Center in Miami Beach, Florida. Primary
participants include certified registered nurse anesthetists (CRNAs) and Anesthesiologists
employed with Miami Beach Anesthesia Associates (MBAA). The participants will be recruited
voluntarily, and the anticipated sample size will be between 5-15 participants.
Description of Approach and Project Procedures
The principal methodology of the proposed quality improvement project is to create and
present an online educational intervention to anesthesia providers from MBAA. This project will
focus on the safety and efficacy of utilizing the ESP block for the perioperative pain
management of cardiac surgical patients. Participants are expected to complete an online pre-test
to assess the providers' knowledge of cardiac surgery and the ESP block. Next, the participants
will watch an approximately 8 minute PowerPoint educating providers on cardiac surgery and
the importance of having safe and effective perioperative pain management. This video will
discuss the anatomy associated ESP block, the technique of performing the ESP block, as well as
compare this block to other regional techniques. Educating providers is crucial to improving
patients' safety and having effective outcomes when they undergo cardiac surgery. Finally, the
participants will partake in a post-test to evaluate whether any knowledge was gained regarding
the ESP block for cardiac surgery. It will also assess the likelihood of the participants to
recommend or use this technique for cardiac surgery. The data attained from this post-test will
deliver feedback regarding the impact of the educational presentation. From this feedback, it may
be determined how to best expand provider knowledge regarding the ESP block for the
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perioperative pain management in cardiac surgery moving forward. The results of this
intervention will also establish if further provider education is required and if it will be helpful to
the practice of other anesthesia providers.
Protection of Human Subjects
The recruitment participants for this study will include CRNAs employed with MBAA
who work at Mount Sinai Medical Center in Hollywood, Florida. This population is significant
because they directly provide care to patients who undergo cardiac surgery and would potentially
benefit from the education delivered. This, in turn, would serve to improve patient outcomes
following cardiac surgery. Recruitment will be conducted via email invitation to all CRNAs and
Anesthesiologists. Participation in this study is voluntary, and there will be no consequences if
participants decide to withdraw. There are no perceived risks to the study as it only requires the
time spent by each participant in the educational intervention.
Data Collection
The primary data collection methods will include a pre-and post-assessment survey to
establish the effects of the educational intervention. These surveys will be conducted through
Qualtrics and will comprise of 9 questions focusing on knowledge and practice. 2 more questions
will evaluate the likelihood of recommending and use of the ESP block for cardiac surgery. The
pre-test survey will assess current knowledge and perceptions of the material that will be
presented. The post-test survey will establish whether knowledge was gained from the
educational intervention. It will also determine whether providers will put what they have
learned into practice. The instrument reliability and validity will be measured per the
intervention provided and its effectiveness for the participants. The data collected will be
confidential, and no subject identifiers will be recorded during any component of the study.
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Data Management and Analysis Plan
The co-investigator for this project will be the DNP student. This co-investigator will be
responsible for administering the survey. Excel software will be utilized to establish whether
participants received any knowledge and possibly adapt their practice in response to the
educational intervention. Each question will be measured, and the responses documented to
identify the knowledge base before and after the intervention and the practical applications of the
intervention. Through the statistical analysis, the study results will detect patterns. These patterns
will be used to determine the effectiveness of the educational intervention and its impact on
clinician practice. The co-investigator will store the collected data in a password-protected laptop
computer.
RESULTS
Participant Demographics
The pre-test demographics are seen in Table 3.
Table 3. Pre-test Participant Demographics
Demographics

N (%)

Total Participants

9 (100%)

Gender
Male

4 (44.4%)

Female

5 (55.5)

Age
18 – 29 yr

3 (33.3%)

30 – 49 yr

6 (66.6%)

50 – 60 yr

0 (0%)

> 60 yr

0 (0%)

Ethnicity
Hispanic

7 (77.7%)

Caucasian

2 (22.2%)

African American

0 (0%)
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Asian/Pacific-Islander
Other

0 (0%)
0 (0%)

Position
MDA

1 (11.1%)

CRNA

8 (88.8%)

Education
Masters

1 (11.1%)

Doctorate

8 (88.8%)

Years of Practice
0 – 2 yr

3 (33.3%)

2 – 5 yr

3 (33.3%)

5 – 10 yr

1 (11.1%)

Over 10 yrs

2 (22.2%)

9 participants accepted being a part of this educational intervention. Of these 9
participants, there were more females (n=5, 55.5%) than males (n=4, 44.4%). Over half of the
participants were between the ages of 30-49 years (n=6, 66.6%), while the rest were between the
ages of 18-29 years (n=3, 33.3%). The only ethnic groups who participated in this study were
Hispanic (n=7, 77.7%) and Caucasian (n=2, 22.2%). Among the participants, a majority had a
doctorate level degree (n=8, 88.8%), the minority being a master’s level degree (n=1, 11.1%). As
of years of practice as an anesthesia provider; 0-2 years (n=3, 33.3%), 2-5 years (n=3, 33.3%), 510 years (n=1, 11.1%), over 10 years (n=2, 22.2%).
Pre-test Knowledge about ESP block for Cardiac Surgery
9 participants completed the pre-test evaluating their current knowledge and insights
about the ESP block and cardiac surgery. Most of the participants (88.8%) knew the proper
location of the ESP block is to be performed at a level of T5-T7. Additionally, over half of the
participants (66.6%) understood that the ESP block shows a minimal risk of bleeding in the
anticoagulated patient. None of the participants (0%) had an understanding that the ESP block
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can be done in cardiac surgery using single-shot unilateral, single-shot bilateral, continuous
unilateral, and continuous bilateral approaches. Two of the participants (22.2%) correctly
answered that the average cost of a CABG is $44,820. Another two participants (22.2%)
understood that the ESP block did not have any of the complications mentioned. All the
participants (100%) correctly answered that regional anesthesia is a crucial aspect of fast-track
multimodal approaches to cardiac surgery. Only one participant (11.1%) knew that TPVB, HTE,
and intercostal blocks should be avoided in cardiac surgery. Two participants (22.2%)
comprehended that a bilateral ESP block at T5 spinous process provides analgesia from T2-T9.
Over half of the participants (77.7%) knew that the ESP block is performed by inserting the
Tuohy needle superior to the ultrasound probe using an in-plane approach in the cephalad to
caudal direction. Surprisingly over half of the participants were extremely likely (44.4%) or
somewhat likely (22.2%) to use the ESP block for cardiac surgery. One participant (11.1%) was
neither likely nor unlikely, and two participants (22.2%) were somewhat unlikely to use the ESP
block for cardiac surgery. Just over half of the participants were either extremely likely (33.3%)
or somewhat likely (22.2%) to recommend using the ESP block for cardiac surgery. The rest of
the participants were neither likely nor unlikely (22.2%) or somewhat unlikely (22.2%) to
recommend using the ESP block for cardiac surgery.
Post-test Knowledge about ESP block for Cardiac Surgery
All 9 participants completed the post-test evaluating their current knowledge and insights
about the ESP block and cardiac surgery. All of the participants (100%) knew the proper location
of the ESP block is to be performed at a level of T5-T7. Additionally, there was increased
understanding (88.8%) that the ESP block shows a minimal risk of bleeding in the anticoagulated
patient. Many participants (77.7%) still didn't know that the ESP block can be done in cardiac
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surgery using single-shot unilateral, single-shot bilateral, continuous unilateral, and continuous
bilateral approaches. Knowledge was significantly increased as 77.7% of participants correctly
answered that the average cost of a CABG is $44,820. 7 participants (77.7%), as opposed to 2
(22.2%), understood that the ESP block did not have any of the complications mentioned. There
was no change in participants (100%) that correctly answered that regional anesthesia is a key
aspect of fast-track multimodal approaches to cardiac surgery. Two more participants for a total
of 3 (33.3%) learned that TPVB, HTE, and intercostal blocks should be avoided in cardiac
surgery. Significant learning took place amongst most participants (88.8%) that a bilateral ESP
block at T5 spinous process provides analgesia from T2-T9. There was no change in knowledge
(77.7%) about how the ESP block is performed by inserting the Tuohy needle superior to the
ultrasound probe using an in-plane approach in the cephalad to caudal direction. After the
educational intervention, participants were either extremely likely (55.5%) or somewhat likely
(33.3%) to use the ESP block for cardiac surgery. One participant (11.1%) remained to be neither
likely or unlikely, and none of the participants (0%) were somewhat unlikely or extremely
unlikely to use the ESP block for cardiac surgery. There was an increase in participants being
either extremely likely (55.5%) or somewhat likely (33.3%) to recommend use of the ESP block
for cardiac surgery. There were decreases in participants being neither likely nor unlikely
(11.1%) or somewhat unlikely (0%) to recommend use of the ESP block for cardiac surgery.
Table 4.
Differences in Pre- and Post-test Responses
CORRECT RESPONSES
THE THORACIC ESP BLOCK IS PERFORMED
BY INJECTING LOCAL ANESTHETIC AT
WHICH LEVELS? T5-T7

PRE-TEST

POST-TEST

DIFFERENCE

88.8%

99.9%

11.1%
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WHICH OF THE FOLLOWING STATEMENTS
ARE TRUE REGARDING THE ESP BLOCK? THE
ESP BLOCK SHOWS MINIMAL RISK OF
BLEEDING IN THE ANTICOAGULATED
PATIENT

66.6%

88.8%

22.2%

WHICH OF THE FOLLOWING TECHNIQUES
ARE EFFECTIVE FOR MANAGING PAIN IN
CARDIAC SURGERY? (SELECT ALL THAT
APPLY) SINGLE-SHOT UNILATERAL ESP
BLOCK, CONTINUOUS UNILATERAL ESP
BLOCK, SINGLE-SHOT BILATERAL ESP
BLOCK, CONTINUOUS BILATERAL ESP
BLOCK
THE AVERAGE COST OF A CABG IS: $44,820

0%

33.3%

33.3%

22.2%

77.7%

55.5%

COMPLICATIONS OF THE ESP BLOCK
INCLUDE: NONE OF THE ABOVE

22.2%

55.5%

33.3%

100%

100%

0%

11.1%

33.3%

22.2%

22.2%
77.7%

88.8%
77.7%

66.6%
0%

A KEY ASPECT OF FAST-TRACK,
MULTIMODAL APPROACHES TO CARDIAC
SURGERY INCLUDES WHAT? REGIONAL
ANESTHESIA
THE FOLLOWING REGIONAL TECHNIQUES
SHOULD BE AVOIDED IN THE
ANTICOAGULATED PATIENT: (SELECT ALL
THAT APPLY) THORACIC PARAVERTEBRAL
BLOCK, THORACIC EPIDURAL,
INTERCOSTAL BLOCK
BILATERAL ESP BLOCK AT THE T5 SPINOUS
PROCESS PROVIDES ANALGESIA FROM: T2-T9
THE ESP BLOCK IS PERFORMED BY
INSERTING THE TUOHY NEEDLE ____ TO THE
ULTRASOUND PROBE USING AN _____
APPROACH IN THE CEPHALAD TO CAUDAL
DIRECTION: SUPERIOR; IN-PLANE

Table 5.
Difference in Pre- and Post-test Likelihood of Use in Practice
HOW LIKELY ARE YOU TO USE THE ESP BLOCK
FOR CARDIAC SURGERY

PRE-TEST

POST-TEST

DIFFERENCE

EXTREMELY LIKELY

44.4%

55.5%

11.1%

SOMEWHAT LIKELY

22.2%

33.3%

11.1%

NEITHER LIKELY NOR UNLIKELY

11.1%

11.1%

0%
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SOMEWHAT UNLIKELY

22.2%

0%

-22.2%

EXTREMELY UNLIKELY

0%

0%

0%

PRE-TEST

POST-TEST

DIFFERENCE

EXTREMELY LIKELY

33.3%

55.5%

22.2%

SOMEWHAT LIKELY

22.2%

33.3%

11.1%

NEITHER LIKELY NOR UNLIKELY

22.2%

11.1%

-11.1%

SOMEWHAT UNLIKELY

22.2%

0%

-22.2%

EXTREMELY UNLIKELY

0%

0%

0%

Table 6.
Difference in Pre- and Post-test Likelihood of Recommendation
HOW LIKELY ARE YOU TO RECOMMEND USE OF
THE ESP BLOCK FOR CARDIAC SURGERY

Summary of Data
The results show there was an overall gain in knowledge between the pre- and post-test
surveys. 7 out of the 9 participants (77.7%) showed improvement in knowledge in their post-test
surveys. The remaining 2 participants (22.2%) had a decrease in knowledge regardless of the
education delivered. Generally speaking, there was a net gain difference in questions answered
correctly in the post-test surveys. Pre-test assessments showed an average score of 45%
compared to an average score of 71%. The overall average improvement between pre- and posttest surveys was 26%. After partaking in this educational intervention, 22.2% of the participants
changed from somewhat unlikely (22.2%) to use the ESP block for cardiac surgery to either
somewhat likely (11.1%), or extremely likely (11.1%). 33.3% of the participants also changed
from neither likely or unlikely (11.1%) or somewhat unlikely (22.2%) to recommend using the
ESP block for cardiac surgery to somewhat likely (11.1%) or extremely likely (22.2%).
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DISCUSSION
Limitations
Limitations of the QI project include a small sample size. The survey was sent to all
anesthesia providers at MBAA via email, but many chose not to partake in the educational
intervention. A larger sample size would have increased the strength and trustworthiness of the
study. Considering the delivery of the study was done completely online, this may have limited
or swayed the results. Not all participants are self-directed learners, and it is possible that
participants may have completed the study in an environment not favorable to learning. A more
controlled, in-person setting could have generated more accurate results.
Future Implications
The results of this study are significant in shaping strategies available to participants that
will improve knowledge and potentially change practice to improve outcomes in patients
undergoing cardiac surgery. According to the data collected, the educational intervention provided
was effective in increasing anesthesia provider knowledge on the ESP block and its current role in
decreasing perioperative pain and opioid consumption. Due to this educational intervention, there
was an increase in the likelihood of utilizing the ESP block for this patient population among the
anesthesia providers involved in the study. The content of this educational intervention can be
applied to a wider audience of anesthesia providers and thereby further increasing provider
awareness.
CONCLUSION
Cardiac surgery is an invasive, painful procedure that can cause debilitating
consequences if perioperative pain is not managed properly. While there are many different
techniques currently being utilized to control perioperative pain related to cardiac surgery, many
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of these have adverse reactions which may further put patients at risk for poor outcomes.
Regional anesthesia is the foundation for controlling pain perioperatively for many different
surgeries. Deploying a regional anesthetic during cardiac surgery is challenging due to the
significant anticoagulation required. The ESP block is a fairly non-invasive regional anesthetic
that shows promising pain control with no significant adverse effects, even in the anticoagulated
patient. Although more studies, including RCTs, must be conducted to ensure the safety and
efficacy of the ESP block during cardiac surgery, it is a promising technique that anesthesia
providers may one day use their everyday practice. Increasing provider awareness of this
emerging technique is the first step in ensuring that anesthesia providers don’t have to shy away
from a regional anesthetic for cardiac surgery.

Appendix A: Matrix Table
Citation and
Theme of the
article

Design/
Method

Sample/Setting

Major
Variables
Studied and
Their
Definitions

Krishna et al.
(2019) . Bilateral
erector spinae
plane block for
acute postsurgical pain in
adult cardiac
surgical patients:
A randomized
controlled tria

A prospective,
randomized,
controlled,
single-blinded
study
examining the
analgesic
efficacy of
bilateral ESP
block
compared with
conventional
treatment for
pain after
cardiac
surgery in
adult patients

106 adult patients
undergoing elective
cardiac surgery

Group 1=
ESP block

n=53 received an
USG single-shot
bilateral ESP block
with 3ml/kg of
0.375%
ropivacaine before
anesthesia
induction
n=53 received
paracetamol 1gm
every 6 hours and
tramadol 50mg
every 8 hours
intravenously
postoperatively
Single-center
tertiary teaching
hospital

Group 2= IV
medications

Measurement and Data Analysis

The clinical data were summarized
and analyzed using SPSS version
21. Data expressed as mean ±
standard deviation or median
(minimum and maximum) and
percentage as appropriate for
continuous and categorical
variables. Data were tested for
normality using the KolmogorovSmirnov test. An unpaired
Student t test was used to compare
continuous variables. For
comparison of ordinal categorical
data, the Pearson chi-squared test
and Mann-Whitney U testwere
used. A value of p < 0.05 was
considered statistically significant.

Findings

Conclusions

The postoperative pain level
after extubation and duration
of analgesia during which
NRS was < 4 of 10 was
compared between the
groups. The median pain
score at rest after extubation
in group 1 was 0 of 10 until
hour 6, 3 of 10 at hour 8,
and 4 of 10 at hours 10 and
12 postextubation. These
were significantly less in
comparison with group 2
(p = 0.0001). Patients in
group 1 had a significantly
higher mean duration of
analgesia (8.98 ± 0.14
hours), during which NRS
was < 4 of 10, compared
with group 2 (4.60 ± 0.12
hours) (p = 0.0001).

ESP block provided
superior analgesia
for a longer duration
compared with
intravenous
paracetamol plus
tramadol regimen

Appraisal:
Worth to
Practice/
Level

Level I
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Singh et al. (2018)
Comparison of
continuous
thoracic epidural
analgesia with
bilateral erector
spinae plane block
for perioperative
pain management
in cardiac surgery

A prospective,
randomized
comparative
clinical study
comparing
TEA with ESP
block for
perioperative
pain
management
in pts having
cardiac
surgery via
median
steronotomy

50 adult patients
undergoing cardiac
surgery
n=25 received a
TEA bolus dose of
0.25% plain
bupivacaine
followed by a
continuous infusion
of 0.125% plain
bupivacaine at the
rate of 0.1ml/kg/h
until 48 hours
postextubation
n=25 received an
USG continuous
bilateral ESP block
bolus dose of
0.25% plain
bupivacaine 15 ml
injected in each of
the catheters
followed by
continuous infusion
of 0.125% plain
bupivacaine at rate
of 0.1 ml/kg/h until
48h postextubation

Group A=
TEA
Group B=
ESP block

Visual analog scale (VAS) was
recorded in both the groups during
rest and cough at the various time
intervals postextubation. Both the
groups were also compared for
incentive spirometry, ventilator, and
ICU duration. Statistical analysis
was performed using the
independent Student's t-test. A value
of P < 0.05 was considered
statistically significant. Data were
expressed as a mean ± standard
deviation. Categorical data were
analyzed using Chi-squared test and
Independent t-test was used to
analyze the continuous variables. A
two-tailed value of P < 0.05 was
considered statistically significant.
Statistical analysis was performed
using MedCalc software version
12.2.1.0

Comparable VAS scores
were revealed at 0 h, 3 h, 6
h, and 12 h (P> 0.05) at rest
and during cough in both the
groups. Group A had a
statistically significant VAS
score than Group B (P ≤
0.05) at 24 h, 36 h, and 48 h
but mean VAS in either of
the Group was ≤4 both at
rest and during cough.
Incentive spirometry,
ventilator, and ICU duration
were comparable between
the groups.

ESP block is easy to
perform and can
serve as a promising
alternative to TEA
in optimal
perioperative pain
management in
cardiac surgery.

Level I
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Fang et al. (2019)
Ultrasoundguided
preoperative
single-dose
erector spinae
plane block
provides
comparable
analgesia to
thoracic
paravertebral
block following
thoracotomy: a
single center
randomized
controlled doubleblind study.

Sobhy et al.
(2020)
Ultrasoundguided erector
spinae block for
postoperative
analgesia in
thoracotomy
patients: a
prospective,
randomized,
observer-blind,

A single center
randomized
controlled
double-blind
study
comparing the
effectiveness
of ESP block
with TPVB for
thoracotomy
incisions

A randomized
single-blind
controlled
clinical trial
investigating
the efficacy of
US-guided
ESP block in
analgesia after
thoracotomies

94 pts scheduled
for thoracotomy
lung surgeries

ESPB group
TPVB group

n=47 received
single shot ESPB
20ml of 0.25%
bupivacaine, then
sufentanil PCA
post-op
n=47 received
single shot TPVB
20ml of 0.25%
bupivacaine, then
sufentanil PCA
post-op

60 pts
n=30 received
single-shot USguided ESP block
with 20 ml 0.25%
bupivacaine
n=30 control group
received
conventional
opioids

ESP group=
received
block
C group=
control
group
receiving
opioids

All statistical analyses were
performed using IBM SPSS for
Windows® version 22.0 software
(SPSS, Chicago, IL, USA). The
Kolmogorov-Smirnov test was used
to determine the normality of data
distribution. Continuous variables
were expressed as mean ± standard
deviation, and median (25th–75th
percentiles), and categorical
variables as counts (percentages).
Comparisons of normally
distributed continuous variables
between the groups were performed
using Student’s t-test, while nonnormally distributed continuous
variables between the groups were
compared using the Mann-Whitney
U test. Comparisons of categorical
variables between the groups were
performed using Fisher’s Exact ChiSquare test, the Yates Chi-Square
test, and the Monte Carlo Chi
Square test. A two-sided P value
<0.05 was considered statistically
significant.

There were no significant
differences in pain scores at
rest and cough between the
ESPB and TPVB groups in
each of the first two days
after surgery, and no
difference between the two
groups was identified
regarding postoperative
sufentanil usage (P>0.05).
There was no statistical
difference in post-operative
nausea and vomiting. There
was significantly less
hypotension
(6.7% vs. 21.7%, P=0.04),
bradycardia (0 vs. 8.7%,
P=0.04), hematoma
(0 vs. 10.9%, P=0.02) and a
higher success rate of one
puncture (82.2% vs. 54.3%,
P<0.001) in the ESPB
group.

Preoperative singleinjection ESPB plus
postoperative
sufentanil PCA
provided similar
effects of pain relief
for patients
undergoing
thoracotomy when
comparing to
TPVB. Yet, ESPB
had the advantages
of a lower adverse
effect incidence.

Level I

The quality of
analgesia based on visual analogue
scale (VAS) pain scores which were
assessed every 6 h for 24 h. The
score is determined by measuring
the distance on the 10-cm line
between the “no pain” and the
“worst possible pain”, providing a
range of scores from 0 to 10. A
higher score indicates greater pain
intensity, no pain (0) and severe
pain (10). The results were
compared using Statistical Package

Results showed that there is
a significant decrease in
total morphine consumption
in the first 24 h
postoperatively in the ESP
group. Also, when
comparing VAS score
during rest and coughing,
results showed that there is a
significant decrease in
VASR and VASC at 6, 12,
18, and 24 h postoperatively
in the ESP group.

Ultrasound-guided
single-shot ESP
block provided
adequate analgesia
following
thoracotomy surgery
and reduced
morphine
consumption
significantly
compared to the
control group.

Level I
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controlled clinical
trial.

Macaire et al.
(2019)
Ultrasoundguided continuous
thoracic erector
spinae plane block
within an
enhanced
recovery program
is associated with
decreased opioid
consumption and
improved patient
postoperative
rehabilitation after
open cardiac
surgery—A
patient-matched,

for the Social Sciences (SPSS Inc.,
Chicago, IL, USA) version 20.
Parametric normally distributed
numerical was presented as (mean ±
SD) and differences between groups
were compared using
Student’s t tests, non-parametric
data was presented as (median and
interquartile range), and differences
between groups were compared
using Mann-Whitney U test,
categorical data were presented as
number and percentage, and
intergroup comparison was
performed using Chi-square test.
Statistically, we consider the results
as significant if the p value was less
than 0.05, and the confidence
interval was 95%.

67 total patients
A consecutive,
patientmatched,
controlled
before-andafter study

n=20 consecutive
open cardiac
surgery patients
without ESPB
block receiving IV
morphine, IV
nefopam, and
paracetamol
n= 47 consecutive
patients receiving
continuous bilateral
ESPB
0.25ml/kg/side of
ropivacaine 0.5%,
then 8 hours after
loading dose,

Group 1:
FTP
protocol
without
ESPB
Group 2:
FTP
protocol
with ESPB

The aim of the present study was to
demonstrate the effectiveness of
ESPB by detecting an almost 30%
difference in 48-hour total morphine
consumption between the 2 groups
of patients. The sample size was
estimated at 20 patients per group
(α = 0.05; β = 0.20 expected
difference). Categorical variables
are expressed as number and
percentage, and quantitative
variables are expressed as median
[interquartile range] or mean ±
standard deviation. The ShapiroWilk test was used to test the
normality of continuous
variables. Univariate analysis was
performed between continuous
variables with the Student t test or

Morphine consumption in
the first 48 hours was
significantly decreased in
the ESPB group (40 [25-45]
mg in the control group
compared with 0 [0-0] mg in
the ESPB group [p < 0.001])
as was
intraoperative sufentanil (0.8
[0.6-0.9] µg/kg/h and 0.2
[0.16-0.3] µg/kg/h,
respectively; p < 0.001).
Times to chest tube
removal, first mobilization,
pain (Visual Analogue
Scale) values 2 hours after
chest tube removal, pain
values at rest 1 month after
surgery, and postoperative

A bundle of care
including a
continuous bilateral
ESPB is associated
with a significant
decrease in
intraoperative and
postoperative opioid
consumption,
optimized rapid
patient mobilization,
and chest tube
removal after open
cardiac surgery.

Level II
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controlled beforeand-after study.

Adhikary et al.
(2019)
Continuous
erector spinae
plane block as an
effective analgesic
option in
anticoagulated
patients after left
ventricular assist
device
implantation: A
case series.

boluses of 0.2%
ropivacaine every 6
hours

A case series
detailing five
patients who
underwent
therapeutic
anticoagulatio
n after LVAD
surgery via
thoracotomy
approach. Four
pts received
continuous
ESP block to
manage acute
postthoracotomy
pain. The fifth
pt received the
continuous
ESPB
preoperatively

4 cases received
continuous ESP
blocks with 20ml
of 0.5%
ropivacaine
followed by
continuous infusion
of 0.2%
ropivacaine at 6 to
10 mL/h
postoperatively for
rescue analgesia
and removed at the
discretion of acute
pain service
1 case received
continuous ESP
block with same
dosage
preoperatively and
continued until the
discretion of acute
pain service

n/a

the Mann-Whitney test for the nonGaussian variables. Categorical
variables were compared with the
chi-square or Fisher exact test, as
appropriate. Multivariate
analysis was performed in order to
study the respective influence of
covariates considered clinically
significant or significantly reported
in the univariate analysis on ESPB.
A test was considered significant if
p < 0.05. Statistical analysis was
performed using SAS, Version 11

adverse events were
significantly decreased in
the ESPB group. There was
no difference
for extubation time and pain
during first mobilization.

Case 1- A 46 kg, 62-year-old
woman underwent implantation of a
HeartWare (Framingham, MA)
LVAD for ischemic
cardiomyopathy. Shortly after block
completion, the patient described
subjective numbness of the left
hemithorax between the T3 to
T9 dermatomes. Her NRS pain
score on deep breathing decreased
from 9/10 to 2/10, and her MIVs
increased to 450 mL, accompanied
by a decrease in her resting
respiratory rate from 25 to 11
breaths per minute.
Case 2- An 86 kg, 65-year-old man
underwent explantation of a
Heartmate II LVAD after
myocardial recovery from previous
cardiomyopathy. Pt reported NRS
pain scores of 10/10, MIVs less than
500ml. Within 2 hours of ESP
block, his resting pain score had
dropped to 0, his respiratory rate
had decreased to 16 from 26 per
minute, and his MIVs improved to

Case 4- A 33-year-old man
presented for a HeartMate II
to HeartMate III LVAD
exchange due to pump
thrombosis. Pt had NRS 810/10 pain and
unmeasurable readings of
MIV. After ESP block, pain
improved to 6/10, narcotic
requirements decreased, and
MIVS improved to
2,000mL, over the next few
days, pain scores improved
to 2-3/10 max of 5/10.
Case 5- An 85 kg, 60-yearold man was scheduled for
elective HeartWare LVAD
implantation. NRS resting
pain score of 2 to 3/10 and 5
to 6/10 with deep
inspiration. Pt also received
Oral Tylenol and IV
hydromorphone 4mg POD 1
and 2

There were no
adverse events
related to catheter
insertion or removal
in the cases
described here nor
in the subsequent
cases that the
authors have
performed to date.
Continuous ESP
block thus is a
feasible option for
managing postthoracotomy pain in
the presence
of anticoagulation.
Continuous ESP
block is a relatively
simple and safe
option that produced
significant opioidsparing and
improved analgesia
after LVAD

Level IV
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1,200 mL. The ESP infusion was
continued for 72 hours, during
which time his pain remained well
controlled with NRS resting pain
scores of 0 to 3/10, rising to 4/10 on
coughing.
Case 3- A 94 kg, 59-year-old man
presented for a HeartMate II to
HeartMate III LVAD exchange due
to pump thrombosis.
Pt received continuous bilateral ESP
block after 10/10 NRS pain and
MIVs of 200ml. After block, there
was rapid improvement in NRS pain
scores to 3/10 and in MIVs to 1,000
mL.
Munoz-Leyva et
al. (2019)
Bilateral
continuous erector
spinae plane
(ESP) blockade
for perioperative
opioid-sparing in
median
sternotomy.

A case series
of five pts
undergoing
cardiac
surgery via
median
sternotomy
receiving
continuous
bilateral ESPB
to provide
opioid-sparing
analgesia

Five patients were
given continuous
bilateral ESPB
preoperatively
using 20 ml of
0.25% bupivacaine
with 2.5mcg/ml of
epinephrine
through each
catheter. The
postoperative
regimen comprised
of 0.125%
bupivacaine at
8ml/h through each
catheter as well as
1g of
acetaminophen
every 6 hours. IV
hydromorphone
given for
breakthrough pain
control if bolus

n/a

Case 1- A 71-year-old woman with
severe aortic stenosis underwent
bioprosthetic aortic valve
replacement surgery. There were no
episodes of breakthrough
pain during the period of ESP
catheter infusion.
Subcutaneous enoxaparin (40 mg
every 12 hours) also was started
during this time as part of the
management of postoperative atrial
fibrillation. Static and dynamic pain
remained well-controlled on
oral acetaminophen (1 g every 6
hours) with NRS scores of 3 to 4/10
and 1/10, respectively. No opioids
were required during her hospital
stay.
Case 2- A 49-year-old man with
severe aortic
insufficiency and aortic root dilation
underwent a Bentall procedure with
mechanical valve prosthesis. The

surgery, leading to
enhanced recovery.

Case 4- A 72-year-old man
with a severe aortic
insufficiency and
aneurysmal aortic dilatation
underwent
bioprosthetic aortic valve
replacement and repair of
the supracoronary aortic root
with a Dacron graft. During
the first 24 hours of his
postoperative care, the
patient received an infusion
of 0.5% lidocaine at 15
mL/h through each ESP
catheter due to a temporary
national shortage of
bupivacaine; thereafter he
received 0.125%
bupivacaine. dynamic and
static NRS pain scores were
maintained at 2/10 and 0/10,
respectively. There were no
episodes of breakthrough

In summary, the
preoperative
insertion of ESP
catheters allowed
the authors to
significantly reduce
perioperative opioid
consumption in
patients undergoing
median sternotomy,
while continuing to
provide excellent
analgesia. The
authors were able to
extubate all but 1 of
the patients in the
operating room, a
strategy that may
reduce the length of
ICU stay. In the
authors’ opinion, it
is also a simpler
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injection of 15ml
of 0.125% of
bupivacaine was
not effective.

patient reported breakthrough pain
with movement at postoperative
hour 4 and 32 (NRS 5/10 and 6/10,
respectively). In both instances, this
was managed by administering a
bolus of 15 mL of 0.125%
bupivacaine into each catheter,
which restored adequate analgesia
(static and dynamic NRS pain
scores <4/10). No opioids were
required during the period of
ESPinfusion. Anticoagulation with
enoxaparin, 1 mg/kg every 12 hours
was started 48 hours following
surgery.
Case 3- A 68-year-old man with
critical disease of the proximal
anterior descending and circumflex
arteries underwent a 2vessel coronary artery bypass graft
surgery with internal mammary
and saphenous vein grafts. The
patient reported dynamic and static
NRS pain scores of 3/10 and 1/10,
respectively, and was started on oral
acetaminophen (1 g every 6 hours)
in addition to the ESP infusion.
There were no episodes of
breakthrough pain during his
hospital stay, even after removal of
the ESP catheters.

pain or any requirement for
opioids during his hospital
stay.
Case 5- A 64-year-old
woman with non-ST
elevation myocardial
infarction and critical
disease of the proximal
anterior descending and
circumflex arteries
underwent a 2-vessel
coronary artery bypass graft
surgery with internal
mammary and saphenous
vein grafts. On arrival, the
patient reported dynamic
and static NRS pain scores
of 8/10 and 4/10,
respectively. A bolus of 15
mL of 0.125% bupivacaine
was administered through
each ESP catheter, which
reduced pain scores by 50%
after 15 minutes. Another
episode of breakthrough
pain occurred at
postoperative hour 12
(dynamic and static NRS
pain scores of 6/10 and 3/10,
respectively). This again
was treated successfully by
bolus administration of
0.125% bupivacaine per
protocol, reducing dynamic
and static pain scores to
3/10 and 2/10 within 15
minutes. No further episodes
of breakthrough pain were
reported, even after removal
of the ESP catheters.

technique compared
to ultrasound-guided
TPVB because the
target (the tip of the
transverse process)
is more superficial
and highly visible
on ultrasound. In
addition, the lack of
proximity to the
neuraxis, major
nerves, or blood
vessels, combined
with the
compressibility of
the site, also
minimizes the risk
of clinically
significant
hemorrhage or
hematoma. Under
these circumstances,
the most recent
guidelines issued by
the American
Society of Regional
Anesthesia and Pain
Medicine support
the judicious use of
the ESP block even
in anticoagulated
patients.
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Appendix B: IRB Exemption

Office of Research Integrity
Research Compliance, MARC 414

MEMORANDUM
To:
CC:

Dr. Vicente Gonzalez
Javier Luces

From:

Maria Melendez-Vargas, MIBA, IRB Coordinator

Date:

April 6, 2021

Protocol Title:

“Use of the Erector Spinae Plane Block for the Perioperative Pain
Management of the Cardiac Surgical Patient: An Educational Module”

The Florida International University Office of Research Integrity has reviewed your research
study for the use of human subjects and deemed it Exempt via the Exempt Review process.
IRB Protocol Exemption #:
TOPAZ Reference #:

IRB-21-0119
110242

IRB Exemption Date:

04/06/21

As a requirement of IRB Exemption you are required to:
1) Submit an IRB Exempt Amendment Form for all proposed additions or changes in the
procedures involving human subjects. All additions and changes must be reviewed and
approved prior to implementation.
2) Promptly submit an IRB Exempt Event Report Form for every serious or unusual or
unanticipated adverse event, problems with the rights or welfare of the human subjects,
and/or deviations from the approved protocol.
3) Submit an IRB Exempt Project Completion Report Form when the study is finished or
discontinued.
Special Conditions: N/A

For further information, you may visit the IRB website at http://research.fiu.edu/irb.

MMV/em
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Re:

IRB Waivers for Quality Improvement Projects with Miami Beach Anesthesiology
Associates

The following students have proposed some interdepartmental education modules. These
quality improvement projects are internal projects belonging to Miami Beach Anesthesiology
Associates. Internal review board approval is not necessary for our departmental improvement
projects per Mount Sinai Medical Center’s advocate, Yvonne Ortiz.
The projects will involve surveying anesthesia providers from Miami Beach Anesthesiology
Associates at Mount Sinai Medical Center of Florida.
Then educational modules performed by the students will be giving a pre-test, Zoom recorded
educational module with a post-test lasting less than 20 minutes.
The following projects have been proposed and approved by our educational department and
deem these projects IRB exempt.
Alyssa Staubitz: An Education Intervention on The Use of Aprepitant versus Ondansetron in the
Prevention of Postoperative Nausea and Vomiting (PONV) in Adult Patients Undergoing General
Anesthesia
Erik Gonzalez: PECS II Block and Its Role in Reducing Opioid Consumption and Acute
Postoperative Pain in Mastectomy Patients: An Evidence Based Educational Module
Michael Otte: An Education Intervention on The Use of Continuous Perioperative
Dexmedetomidine Infusion to Reduce Opioid Consumption in Adult Patients Undergoing Spinal
Lumbar Surgery
Brittany Williams: Use of a Structured Educational Program to Expand the Knowledge of CRNAs
Regarding Post-Traumatic Stress Disorder and the Existing Body Of Research of 3,4Methylenedioxymethamphetamine Assisted Psychotherapies in Patients Suffering from this
Disorder and Others Alike
Israel Lopez: Educational Intervention Regarding the Effectiveness of Single Dose Intraoperative
Methadone Reducing Post-Operative Opioid Consumption at 24-48 Hours: A Quality
Improvement Project
David Luth: Transcutaneous Electrical Acupoint Stimulation to Decrease Opiate Utilization in
Surgical Patients: An Evidence Based Educational Module
Weslin Roldan: Pharmacological Evidence-Based Algorithm in the Management of Awake
Fiberoptic Intubation: A Quality Improvement Project
Karina Grubb: Educational Intervention Regarding the Utilization of P6 Acustimulation to
Decrease PONV in Women 18 Years of Age and Older: A Quality Improvement Project
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Danielle Agostino: Education Intervention Regarding Utilization of the
Quadratus Lumborum Block for Post-Operative Analgesia Following
Abdominal Surgery
Cesar Lopez: Prophylactic Administration of Methylene Blue to Surgical
Patients to Prevent Hypotension after Cardiopulmonary Bypass: An
Educational Module for Anesthetic Practice
Javier Luces: Use of the Erector Spinae Plane Block for the Perioperative
Management of the Cardiac Surgical Patient: An Education Module
Please don’t hesitate to contact our department with any questions
and/or concerns
Kindly,
Gerald P. Rosen M.D., FASA
Miami Beach Anesthesiology Associates
Program Director, Anesthesiology Residency
Mount Sinai Medical Center
4300 Alton Road, Miami Beach, FL
Gerald.rosen@msmc.com
grosen167@me.com
305 469-8348
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Appendix C: QI Project Consent

CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
“Use of the Erector Spinae Plane Block for the Perioperative Pain Management of the Cardiac
Surgical Patient: An Educational Module”
PURPOSE OF THE PROJECT
You are being asked to be in a quality improvement project. The goal of this project is to
increase anesthesia provider’s awareness of the safety and efficacy of utilizing the thoracic ESP
block for cardiac surgery through an education module.
DURATION OF THE PROJECT
Your participation will require about 25 minutes of your time.
PROCEDURES
If you agree to be in the project, we will ask you to do the following things:
Complete and sign a consent form for participation, complete a pre-test questionnaire, view an
approximately 10 minute long educational presentation online, and asked to complete the posttest questionnaire.
RISKS AND/OR DISCOMFORTS
There are no foreseeable risks with you for participating in this project.
BENEFITS
The following benefits may be associated with your participation in this project: An increase in
the knowledge associated with the benefits of utilizing thoracic ESP blocks for cardiac surgery.
Utilizing this technique in clinical practice may be associated with increased patient satisfaction
and improved patient outcomes.
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ALTERNATIVES
There are no known alternatives available to you other than not taking part in this project.
However, if you like to receive the educational material given to the participants in this project, it
will be provided to you at no cost.
CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent provided
by law. If, in any sort of report, we might publish, we will not include any information that will
make it possible to identify you as a participant. Records will be stored securely, and only the
project team will have access to the records.
COMPENSATION & COSTS
There is no cost or payment to you for receiving the health education and/or participating in this
project.
RIGHT TO DECLINE OR WITHDRAW
Your participation in this project is voluntary. You are free to participate in the project or
withdraw your consent at any time during the project. Your withdrawal or lack of participation
will not affect any benefits to which you are otherwise entitled. The investigator reserves the
right to remove you without your consent at such time that they feel it is in the best interest.
RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
research project, you may contact Javier Luces. at 786-972-5072, jluce004@fiu.edu or Dr. Vince
Gonzalez at 305-348-0062, gonzalv@fiu.edu
IRB CONTACT INFORMATION
If you would like to talk with someone about your rights of being a subject in this project or
about ethical issues with this project, you may contact the FIU Office of Research Integrity by
phone at 305-348-2494 or by email at ori@fiu.edu
PARTICIPANT AGREEMENT
By clicking the button below, you have read the information in this consent form and agree to
participate in this project.
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Appendix D: QI Project Survey

Pretest and Posttest Questionnaire:
Thoracic ESP block for Cardiac Surgery
INTRODUCTION
The primary aim of this QI project is to improve the knowledge of anesthesia providers
pertaining to the safety and efficacy of the use of thoracic ESP block for cardiac surgery.
Please answer the question below to the best of your ability. The questions are in multiple
choice and true and false format and are meant to measure knowledge and perceptions on the
thoracic ESP block.
PERSONAL INFORMATION
1. Gender: Male

Female

Other________

Caucasian

African American

2. Age: ______
3. Ethnicity:
Hispanic

Asian

Other_______________
4. Position/Title: _________________________________
5. Level of Education: Bachelors

Masters

Doctorate

___________
6. How many years have you been an anesthesia provide?
Over 10

5-10 years

2-5 years
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QUESTIONNAIRE
1. The thoracic ESP block is performed by injecting local anesthetic at which levels?
a. T1-T2
b. T12-L3
c. T5-T7
d. C7-T2
2. Which of the following statements are true regarding the ESP block?
a. The ESP block shows significant risk of bleeding in the anticoagulated patient
b. The ESP block shows minimal risk of bleeding in the anticoagulated patient
c. Bleeding is never a concern when performing an ESP block
d. The ESP block shows moderate risk of bleeding in the anticoagulated patient
3. Which of the following techniques are effective for managing pain in cardiac
surgery? (Select all that apply)
a. Single-shot Unilateral ESP block
b. Continuous Unilateral ESP block
c. Single-shot Bilateral ESP block
d. Continuous Bilateral ESP block
4. The average cost of a CABG is:
a. $52,800
b. $74,340
c. $44,820
d. $29,480
5. Complications of the ESP block include:
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a. Pneumothorax
b. Spinal cord injury
c. Vascular puncture
d. None of the above
6. A key aspect of fast-track, multimodal approaches to cardiac surgery includes
what?
a. Regional Anesthesia
b. Opioids
c. IV medications
d. Off-pump techniques
7. The following regional techniques should be avoided in the anticoagulated patient:
(Select all that apply)
a. Thoracic paravertebral block
b. Thoracic ESP block
c. Thoracic epidural
d. Intercostal block
8. Bilateral ESP block at the T5 spinous process provides analgesia from
a. C5-T7
b. T2-T9
c. T4-T9
d. T2-T7
9. The ESP block is performed by inserting the Tuohy needle ____ to the ultrasound
probe using an _____ approach in the cephalad to caudal direction
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a. superior; in-plane
b. inferior; in-plane
c. superior; out-of-plane
d. inferior; out-of-plane
10. How likely are you to consider using thoracic ESP block for cardiac surgical patients?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
11. How likely are you to recommend thoracic ESP block for cardiac surgery?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
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Appendix E: QI Educational Module

Learning Goals
Upon hearing this education module,
the anesthesia provider will understand:

USE OF THE ERECTORSPINAE PLANE
BLOCK FORTHE PERIOPERATIVE
MANAGEMENT OF THE CARDIAC
SURGICAL PATIENT: AN EDUCATION
MODULE
Presented b y:
Javier Luces BSN , RN
Team M em b ers:

Background
information on cardiac
surgery

Dr. Vince Go nzalez DN P, CRN A, APRN

The need for safe and
effective regional
techniques for cardiac
surgery

Risks and side effects of
other regional
techniques commonly
used for thoracic
surgery.

Risks and benefits of
the Erector spinae
plane block (ESP) in
cardiac surgery

The different
techniques of the ESP
block and the anatomy
anatomy associated
with this regional
technique

Acute and Chronic
Pain After Cardiac
Surgery

Background
One of the most common surgeries in America is a coronary artery bypass
grafting (CABG), costing an average of $44,820

◦ Approximately 2 million patients who undergo
cardiac surgery suffer from persistent pain
known as chronic post-sternotomy pain

Fast-track, multimodal approaches to cardiac surgery have been proven to
be safer for patients and more cost-effective than traditional methods of
high opiate use

◦ Severe uncontrolled pain negatively affects
patient recovery

Regional anesthesia has been the foundation of opioid-sparing/free
analgesia in recent years

◦ This can lead to tachycardia, arrhythmias, and
hypertension; all considered detrimental to postcardiac surgical patient

Cardiac surgery brings about its own challenges with regional anesthesia
due to the need for increased anticoagulation perioperatively

◦ Atelectasis, pneumonia, and coagulation
disorders can all be attributed to this pain

Traditionally, high thoracic epidurals (HTEs) and thoracic paravertebral
blocks (TPVBs) are effective regional techniques for patients undergoing
thoracic surgery

◦ Managing pain acutely is crucial to decreasing
chronic pain, and therefore increasing patients’
quality of life, satisfaction, and productivity

High Thoracic Epidural Adverse Effects
Epidural
hematoma

Pruritis

Nausea and
Vomiting

Urinary
retention

Respiratory
depression

Failure rate
as high
as15%

THORACIC
PARAVERTEBRAL
BLOCK ADVERSE
EFFECTS

Inadvertent
vascular
puncture

Hypotension

Epidural or
intrathecal
spread

Puncture of
the pleura

Pneumothorax

Erector Spinae Plane Block
◦ The erector spinae muscle is a
complex formed by the spinalis,
longissimus thoracis, and
longissimus muscles that run
vertically in the back
◦ The ESP block is performed by
depositing local anesthetic (LA) in
the fascial plane, deeper than the
ESM at the tip of the transverse
process of the vertebra at any level
between T5-T7

Produces analgesia similar to TPVB without a
potential needle-pleura interaction
Spread of analgesia from T2 to T9

Advantages of
ESP Block for
Cardiac
Surgery

◦ The LA diffuses anteriorly to the
paravertebral and epidural spaces,
and laterally to the intercostal space

Provides extensive cranial-caudal spread
Better coverage of multiple dermatomes with a
single injection
Simpler and safer alternative in anticoagulated
patients
Minimal adverse effects, if any, have been
recorded with the ESP block

◦ The LA exerts its effect on the ventral
and dorsal ramus of the spinal nerve
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The ESP block may be the future of regional
anesthesia in cardiac surgery

In the studies conducted, pain control was
achieved with the same efficacy as HTE and
TPVB

Conclusion

Unfortunately, more randomized control trials
must be conducted in the future to ensure its
safety and efficacy
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